Millennium Management’s Oncobiologics, Inc. Series B Warrant ONSIZ Stock Holding History

Millennium Management’s Portfolio ONSIZ Stock Details ONSIZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-29,658	Closed	-$1K	–	4442
2018 Q1	$1K	Sell	29,658 -6,005	-17%	-$236	﹤0.01%	3581
2017 Q4	$1K	Sell	35,663 -2,700	-7%	-$133	﹤0.01%	3751
2017 Q3	$2K	Sell	38,363 -900	-2%	-$59	﹤0.01%	3458
2017 Q2	$4K	Sell	39,263 -1,761	-4%	-$321	﹤0.01%	3399
2017 Q1	$21K	Sell	41,024 -1,200	-3%	-$519	﹤0.01%	3424
2016 Q4	$33K	Sell	42,224 -1,170	-3%	-$901	﹤0.01%	3268
2016 Q3	$52K	Sell	43,394 -1,531	-3%	-$1.12K	﹤0.01%	3186
2016 Q2	$20K	Buy	+44,925	New	+$23.6K	﹤0.01%	3105

Millennium Management's ONSIZ Position: Q2 2018 in Review

Millennium Management sold out of Oncobiologics, Inc. Series B Warrant (ONSIZ) in Q2 2018, closing a stake of 29,658 shares — an estimated $1K sold.

Millennium Management first reported a position in ONSIZ in Q2 2016 and held it in 8 quarters. The position peaked at $52K in Q3 2016. 0 funds tracked by Wall St. Rank hold ONSIZ as of Q2 2018.

Millennium Management reported no remaining Oncobiologics, Inc. Series B Warrant position as of Q2 2018 after selling out during the quarter.
Millennium Management sold 29,658 Oncobiologics, Inc. Series B Warrant shares in Q2 2018, an estimated $1K.
Millennium Management first reported a position in Oncobiologics, Inc. Series B Warrant in Q2 2016 and held it in 8 quarters.
Millennium Management's Oncobiologics, Inc. Series B Warrant position peaked at $52K in Q3 2016.
0 funds tracked by Wall St. Rank held Oncobiologics, Inc. Series B Warrant as of Q2 2018.

Based on Millennium Management's 13F filing for Q2 2018, filed 14 Aug 2018.